Abbott’s Low-dose Antiretroviral for Children Receives FDA Approval

November 14, 2007 at 2:52 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Abbott’s Low-dose Antiretroviral for Children Receives FDA Approval
Abbott Laboratories on Monday announced that it has received FDA approval to market and sell a lower-dose version of its antiretroviral drug Kaletra for children, the Chicago Sun-Times reports.

The tablet will be available in the U.S. this month, Bloomberg/Chicago Tribune reports. Kaletra has been available in liquid form for children since 2000, but the company in August warned health care providers to be cautious in prescribing Kaletra to children after the death of an infant who received an accidental overdose of the drug, Bloomberg/Chicago Tribune reports.

The new, lower-dose tablets can be taken with or without food and do not require refrigeration, which is an important advantage in treating children in developing countries, Abbott said. The new tablet will cost $2,100 annually per patient in the U.S. and $250 per patient annually in developing countries, the company said. The company added that approval in the European Union is pending, and once approved, it intends to make the drug available in more than 150 countries.

"We are expecting" the first step toward approval in the E.U. soon, Julie Herlocker, a spokesperson for Abbott, said, adding the company has an agreement with European regulators to ship the drug if it is requested directly by medical personnel.

"HIV/AIDS continues to have a devastating impact globally, especially among the more than two million children living with the disease throughout the world," Scott Brun, divisional vice president for infectious disease development at Abbott, said, adding, "Abbott developed a lower-strength tablet formulation of Kaletra to give physicians an innovative treatment option to help curb the impact of HIV infection in children".

Source-Kaiser Family Foundation
LIN/P

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Men's Health Center

Drug Related News

» Revision in Quality Standards for Heparin » Acne Drug Users At High Risk of Developing Eye Infections
» Patients Who Take Antidepressants When in ICU More Likely to Die » New Tablet Coating Product by Ideal Cures, In Geneva
» Prednisolone Benefits Patients With Bell's Palsy » 'Orphan' Sleep Drug may Fight Cancer
» New Drugs for Fox Tapeworm Infection » Poor Quality Antimalarial Drugs Pose Threat
Read More >>